Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Eurovision
Social Media
Baseball
Pope Francis
Israel-Hamas Conflict
Hamas
Boxing
Natural Disasters
Artificial Intelligence
Premier League
Vladimir Putin
European Union
Published • loading... • Updated

Data from Phase 3 trial testing mitapivat in SCD expected this year

Summary by Sickle Cell Disease News
Toop-line data from RISE UP, a clinical trial testing Agios' mitapivat for treating sickle cell disease, is expected by year's end.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Sickle Cell Disease NewsSickle Cell Disease News

Data from Phase 3 trial testing mitapivat in SCD expected this year

Toop-line data from RISE UP, a clinical trial testing Agios' mitapivat for treating sickle cell disease, is expected by year's end.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sickle Cell Disease News broke the news in on Tuesday, May 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

United States

United States

News
For You
SearchBlindspotLocal